Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Safe?

Over the last decade, intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents have been increasingly used in the management of various retinal diseases, especially diabetic macular oedema. Diabetic macular oedema is one of the leading causes of legal blindness among patients with dia...

Full description

Bibliographic Details

Published in:	European Medical Journal Diabetes
Main Authors:	Kuan Hao Yee, Srinivasan Sanjay
Format:	Article
Language:	English
Published:	European Medical Journal 2017-10-01
Subjects:	read-2 bolt da vinci drcr protocol t safety adverse events aflibercept pegaptanib laser diabetic macular oedema bevacizumab ranibizumab anti-vascular endothelial growth factor
Online Access:	https://www.emjreviews.com/diabetes/article/anti-vascular-endothelial-growth-factor-therapy-in-diabetic-macular-oedema-is-it-safe/